Urtica Sp. z o.o. secures contract for Pharmaceutical Products - Delivery of the drug from the drug program The active substance Nintedanibum for use in the drug treatment program for patients with interstitial lung disease under the framework agreement

Poland, Sept. 1 -- Poland based Urtica Sp. z o.o. has secured contract from Szpital Chorob Pluc i Opieka Dlugoterminowa im. sw. Jana Pawla II w Gornie for Pharmaceutical Products - Delivery of the drug from the drug program The active substance Nintedanibum for use in the drug treatment program for patients with interstitial lung disease under the framework agreement. The value of the contract is not disclosed.

Published by HT Digital Content Services with permission from Pivotal Sources....